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Purpose. Head and neck cancer treatment is associated with signiﬁcant morbidities. Both exclusive radiotherapy (RT) and
chemoradiotherapy (CHRT) treatments can produce, as side effects, increased rates of long-term dysphagia. The purpose of the
study here presented was to evaluate the ability of videoﬂuoroscopy (VDF) in detecting and measuring swallowing dysfunction
secondary to treatments.
Methods and materials. Eight head-and-neck cancer patients, who underwent radical RT till 70Gy (5 fractions per week, 2Gy per
fraction), and concurrent chemotherapy (CHT)when indicated, were included. Treatment schedules administered to each patient
(RT total dose, radiation ﬁelds, delivery techniques, CHT schemes) were decided according the NCCN recommendations. Half
of patients received exclusive RT and the other half concomitant CHRT. In order to evaluate a possible swallowing dysfunction,
VDF were performed before and after the treatment. Patients presenting swallowing dysfunction before the treatment were
excluded. Post-treatment evaluation was undertaken twice: early (1–3 months) and late post-therapy (4–9 months). The VDF
explored swallowing dysfunction with the standard different textures.
Results. 3 patients developed some swallowing dysfunction in early post-therapy evaluation and, in the late post-therapy evalua-
tion, 7 patients showed propulsive defect of the pharynx and 6 of them had also residue. Only one patient had symptoms related
to this dysfunction. No case of pneumonia by aspiration was reported.
Conclusions. Swallowing dysfunction is a prevalent side effect after intensive RT and CHRT treatment in head-and-neck cancer
patients. In our ﬁrst 8 patients included, most frequent swallowing dysfunction was the propulsive defect of the pharynx asymp-
tomatic in most of the cases. VDF was very effective in detecting, measuring and controlling this side effect. However, in order
to conﬁrm these results, inclusion of more patients is required. Therefore, patient enrolment continues.
http://dx.doi.org/10.1016/j.rpor.2013.03.290
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Introduction. Radiation therapy is an effective treatment in primary/recurrent head and neck cancer (HNC) arising in previously
irradiated volumes (PIVs) but severe late toxicities have been related.
Objective. To assess the efﬁcacy and toxicity of Helical Tomotherapy (HT) as re-irradiation treatment in primary/recurrent HNC
in PIVs.
Materials and methods. From August 2009 to February 2013, 20 HNC patients with prior-radiation have been re-treated with HT. A
median age of 62 years (range, 41–79 years). Sixty-ﬁve percent of tumors were recurrences emerging in PIVs: skull base (n=4),
pharynx (n=3), oral cavity (n=1), nasopharynx (n=1), nodal cervical area (n=1), facial area (n=2), tiroid area (n=1). Thirty-ﬁve
percent were second primary tumors in PIVs: nasopharynx (n=2), oropharynx (n=2), oral cavity (n=1), hypopharynx (n=1), and
nasal fossa (n=1). Six patients (30%) underwent surgical resection prior re-irradiation. Previous dosimetry (dose distriburion,
prescrioption dose and dose delivered to organs at risk) was taken into account in re-irradiation treatment planning. Concomi-
tant/neoadyuvant platinum-based chemotherapy was administrated in 55% of patients. Toxicities were documented according
to the RTOG scoring criteria.
Results. Median follow-up was 9 months (range, 1–37 months). The median radiation dose in patients with surgical resection
(n=6) was 63Gy (range, 48.6–70Gy), two patients received 70Gy for gross tumor in surgical margin. The patients with irresectable
tumor (n=14) received a median radical doses of 68.3Gy (range, 52–70.2Gy). The relevant toxicity RTOG ≥3 was: acute toxicity:
grade 3: 25% (radiodermatitis n=2, mucositis n=3); Grade 4–5: 0%; Late toxicity (evaluated in 16 patients due to the limited
time of follow-up) was: Grade 3: 13% (xerostomia: n=1, aplasia n=1); Grade 4–5: 0%. At time of analysis 2 local progressions, 3
locorregional and 7 distant failures have been observed.
Conclusions. According to our data, HT could be considered as a radiation option in patients previously irradiated as showed by
an acceptable proﬁle of toxicity.
http://dx.doi.org/10.1016/j.rpor.2013.03.291
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Introduction. IMRT allows normal tissue preservation of uninvolved anatomical structures immediately adjacent to the tumor in
nasopharyngeal carcinoma (NPC) patients.
Objective. To determine the toxicity of IMRT in NPC patients treated with Helical Tomotherapy (HT) or Linac.
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Materials and methods. From August 2009 to August 2013, 38 NPC patients were treated with Linac (32%) and HT (68%), 34 males
and 4 females, with a median age of 51 years (range, 15–78years). Tumor stage: I: 5%; II: 18%; III: 34%; IVa: 34%; IVb: 8%, according
to AJCC 7th ed. Histopathological analysis revealed that 42% were undifferentiated carcinomas, 26% linfoepiteliomas and 32%
squamous cell carcinomas. Median radiation dose of 70Gy to gross tumor volume and positive neck nodes, 66Gy to clinical
target volume, and 54Gy to clinically negative neck, in 33 fractions was delivered. Ninety percent of patients received concurrent
platinum-based chemotherapy. Side-effects were evaluated according to RTOG criteria.
Results. Acute RTOG complicationswere: Grade 1–2 in 76% of patients (radiodermatitis n=22,mucositis n=17, nausea n=1, aplasia
n=1), Grade 3 in 58% (radiodermatitis n=5, mucositis n=20, aplasia n=1), Grade 4 in 11% (aplasia: n=4). Late RTOG complications
were: Grade 1–2 in 74% (xerostomia n=28), Grade 3 in 11% (xerostomia: n=4) and Grade 4 in 3% (dysphagia n=1). Acute or
late Grade 5 complications, mandibular osteorradionecrosis or temporo-mandibular joint dysfunction were not observed. After
a median follow-up of 18 months, the 3-year actuarial local, locoregional and distant control rates were 89%, 95%, and 94%
respectively and the 3-year actuarial progression free survival and overall survival rates were 72% and 85% respectively.
Conclusions. Effectivity in terms of tolerance is compared favourablywith conventional radiotherapy showing in our data excellent
rates of tumor response. Not an increase of the acute toxicity and acceptable late toxicity rates support the IMRT in NPC.
http://dx.doi.org/10.1016/j.rpor.2013.03.292
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Introduction. IMRT, IGRT and 18FDG PET-CT planning in patients with nasopharyngeal carcinoma have shown a contribution not
only in the accuracy when outlining target volumes but also in the delivery of the radiation treatment and therefore reducing
dose in organs at risk.
Aim. Assess clinical and dosimetric outcomes as well as toxicity in the setting of patients with NC.
Methods. All patients with NC treated with radiotherapy have been included in this analysis.
Results. A total of 18 patients with NC have been treated between April 2008 and September 2012 with radical intention. The
average age was 54 years (range 31–70) and the 77.7% of patients had positive nodes at diagnosis. The 94.4% of the sample
received concomitant Chemotherapy and 16 out of the 18 (88.9%) used a gastrostomy feeding tube. All the patients received
radiation therapy with Steep and Shoot IMRT and planning simulation was performed with 18FDG PET-CT in the 72.2% of the
sample. The prescription dose was 66Gy in 30 fractions with and integrated boost of 2.2Gy per fraction in areas with macroscopic
involvement and 54–60Gy in 30 fractions of 1.8–2Gy per fraction in the regions at risk of microscopic spread. IGRT (Cone Beam
CT) was used for treatment veriﬁcation in all the cases. DVH were assessed according to institutional constraints. The mean
follow up was 14.6 months (median: 8 months; range: 1.4–51.17 months). 1 year local failure free survival (LFFS) is 100% and the
2-year actuarial LFFS is 75%. G3 and G4 acute mucositis was 50% and 5.6% respectively. The 83.3% completed treatment without
interruptions.
Conclusion. IMRT, IGRT and 18FDG PET-CT are perfectly integrated in the clinical management of patients with NC allowing
acceptable clinical and dosimetric results.
http://dx.doi.org/10.1016/j.rpor.2013.03.293
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Introduction. Early stage glottis cancer can be successfully treated with radiotherapy. The 5-year disease-speciﬁc survival rate is
90%. It seems that with treatment by radiotherapy we achieve good rates of local control, nevertheless, we live now in commu-
nication era, the success of our treatment depends also on one of the most important parameters in the quality of live for our
patients: the preservation of voice quality.
Objective. To present the design of a pioneering prospective study that will analyze with a multidisciplinary approach the func-
tional results (voice quality), oncology results and the quality of life in patients diagnosed of early glottis cancer and treated
exclusively with radiation.
Material and methods. Male patients diagnosed of early vocal cord carcinoma (T1–T2 N0M0), in whom radiation therapy is the
deﬁnitive treatment decided at the Head&Neck tumour-board. The patients will be studied at the voice unit of otolaryngology
clinic and will have aerodynamic test, perceptual voice valuation, registration of changes in prosody rhythm, digitized acoustic
